Allograft Research Technologies Inc Nashville, TN - 37211

Allograft Research Technologies Inc is categorized under Research Institute in Nashville, TN and active since 2002.

Allograft Research Technologies Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Thomas L Meredith at the company’s single location by writing to 4015 Travis Drive, Nashville, Tennessee TN 37211 or by phoning (615) 832-7167. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Allograft Research Technologies Inc
Contact Person: Thomas L Meredith
Address: 4015 Travis Drive, Nashville, Tennessee 37211
Phone Number: (615) 832-7167
Annual Revenue (USD): $100.000 to $499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research Institute
SIC Code: 8733
NAICS Code: 541712
Share This Business:

Allograft Research Technologies Inc was started in 2002 to provide professional Research Institute under the SIC code 8733 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Thomas L Meredith for inquiries that concern Allograft Research Technologies Inc by calling the company number (615) 832-7167, as your correspondence is most welcome. Additionally, the physical location of the single location of Allograft Research Technologies Inc can be found at the coordinates as well as the street address 4015 Travis Drive in Nashville, Tennessee 37211.

For its online presence, you may visit Allograft Research Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.